Y
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
Price:
15.88
HKD
Market Cap:
HK$14B
Relative Value
The Relative Value of one YiChang HEC ChangJiang Pharmaceutical Co Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 15.88 HKD, YiChang HEC ChangJiang Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
YiChang HEC ChangJiang Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
YiChang HEC ChangJiang Pharmaceutical Co Ltd Competitors
YiChang HEC ChangJiang Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
Y
|
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
|
14B HKD | 3.3 | 25.5 | 11.1 | 17.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
963B USD | 14.8 | 46.7 | 31.4 | 33.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
599.3B USD | 6.4 | 22.4 | 15.5 | 19.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
288.1B CHF | 4.7 | 30.6 | 12.9 | 15.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
250B CHF | 5.7 | 23 | 14.2 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.1B GBP | 5.4 | 31.2 | 17.3 | 24.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.9B USD | 4.6 | 16.5 | 10.2 | 12.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.7B USD | 2.6 | 17.8 | 7.4 | 9.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
